title: Generics, Supergenerics and Patent Strategies--SMi's 13th Annual Meeting.
abstract: SMi's 13th Annual Meeting on Generics, Supergenerics and Patent Strategies, held in London, included topics covering new trends in the generics field, the difficulties faced by companies in entering the generics market and recent developments in IP. This conference report highlights selected presentations on generics in India, protecting pharmaceutical products in China, changes in generics law and litigation in the US and Europe, challenges for market selection and entry for generics companies, the influence of changes in the healthcare market on the generics industry, supergenerics, and biosimilars.
authors.affiliation: Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. cathy.edwards@thomsonreuters.com
authors.forename: Catherine
authors.initials: C
authors.lastname: Edwards
mesh_terms: D001688:Biological Products / Q000191:economics; D002681:China; D003695:Delivery of Health Care / Q000639:trends; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000639:trends*; D016568:Drugs, Generic / Q000191:economics; D005062:European Union; D006801:Humans; D007194:India; D040541:Marketing / Q000191:economics / Q000639:trends; D010330:Patents as Topic; D013810:Therapeutic Equivalency; D014481:United States
chemical_list: D001688:Biological Products; D016568:Drugs, Generic